Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,199 | 5 | 60.4% |
| Food and Beverage | $526.24 | 10 | 26.5% |
| Consulting Fee | $200.00 | 1 | 10.1% |
| Education | $61.03 | 1 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $1,479 | 11 | $0 (2019) |
| TESARO, Inc. | $261.03 | 2 | $0 (2019) |
| ABBVIE INC. | $125.00 | 1 | $0 (2024) |
| Genentech USA, Inc. | $67.56 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $39.00 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $14.25 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $178.25 | 3 | ABBVIE INC. ($125.00) |
| 2019 | $1,540 | 12 | Merck Sharp & Dohme Corporation ($1,479) |
| 2018 | $267.56 | 2 | TESARO, Inc. ($200.00) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $39.00 | General |
| Category: Oncology | ||||||
| 10/03/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | Cash or cash equivalent | $20.84 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | In-kind items and services | $145.77 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $49.97 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | In-kind items and services | $47.37 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | Cash or cash equivalent | $24.63 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | In-kind items and services | $708.56 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | Cash or cash equivalent | $151.15 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | In-kind items and services | $145.77 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: ONCOLOGY | ||||||
| 02/08/2019 | TESARO, Inc. | ZEJULA (Drug) | Education | In-kind items and services | $61.03 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2018 | TESARO, Inc. | ZEJULA (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: ONCOLOGY | ||||||
| 03/26/2018 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $67.56 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 227 | 246 | $40,660 | $16,956 |
| 2022 | 9 | 213 | 283 | $154,050 | $27,423 |
| 2021 | 11 | 315 | 434 | $661,271 | $63,827 |
| 2020 | 12 | 301 | 404 | $406,765 | $47,233 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 24 | 24 | $7,416 | $2,924 | 39.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 41 | 46 | $6,523 | $2,848 | 43.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 24 | 25 | $2,552 | $706.08 | 27.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 12 | 13 | $411.00 | $306.04 | 74.5% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2020 | 14 | 14 | $148,520 | $10,524 | 7.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 49 | 117 | $22,573 | $10,415 | 46.1% |
| 58661 | Removal of ovaries and/or tubes using an endoscope | Facility | 2020 | 13 | 13 | $89,859 | $7,015 | 7.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 77 | 101 | $13,440 | $5,616 | 41.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 31 | 31 | $9,292 | $4,177 | 44.9% |
| 38570 | Removal of abdominal cavity lymph nodes using an endoscope | Facility | 2020 | 12 | 12 | $83,682 | $2,518 | 3.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 23 | 23 | $5,103 | $2,341 | 45.9% |
| 38900 | Lymph node imaging during surgery | Facility | 2020 | 11 | 11 | $25,714 | $1,923 | 7.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 18 | 25 | $4,109 | $1,055 | 25.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 22 | 24 | $2,037 | $969.73 | 47.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 19 | 21 | $2,068 | $446.01 | 21.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 12 | 12 | $368.00 | $234.30 | 63.7% |
About Dr. Evelyn Fleming, M.D
Dr. Evelyn Fleming, M.D is a Gynecologic Oncology healthcare provider based in Lebanon, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780616219.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Evelyn Fleming, M.D has received a total of $1,986 in payments from pharmaceutical and medical device companies, with $178.25 received in 2024. These payments were reported across 17 transactions from 6 companies. The most common payment nature is "Travel and Lodging" ($1,199).
As a Medicare-enrolled provider, Fleming has provided services to 1,056 Medicare beneficiaries, totaling 1,367 services with total Medicare billing of $155,440. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Gynecologic Oncology, Gynecologic Oncology
- Location Lebanon, NH
- Active Since 07/07/2006
- Last Updated 11/05/2024
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1780616219
Products in Payments
- MK-7339 (Drug) $1,479
- ZEJULA (Drug) $261.03
- ELAHERE (Drug) $125.00
- Avastin (Biological) $67.56
- LYNPARZA (Drug) $39.00
- JEMPERLI (Biological) $14.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Lebanon
Dr. Michael Pearl, M.d, M.D
Gynecologic Oncology — Payments: $324.31
Ivy Wilkinson-Ryan, Md, MD
Gynecologic Oncology — Payments: $133.26
Dr. Loyd West, M.d, M.D
Gynecologic Oncology — Payments: $45.94
Ariel Kredentser, M.d, M.D
Gynecologic Oncology — Payments: $36.00
Christianne Persenaire, M.d, M.D
Gynecologic Oncology